Product Name:methyl 4-(hydroxymethyl)picolinate

IUPAC Name:methyl 4-(hydroxymethyl)pyridine-2-carboxylate

CAS:317335-15-2
Molecular Formula:C8H9NO3
Purity:97%
Catalog Number:CM178754
Molecular Weight:167.16

Packing Unit Available Stock Price($) Quantity
CM178754-50g in stock ſſƼDz

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:317335-15-2
Molecular Formula:C8H9NO3
Melting Point:-
Smiles Code:O=C(OC)C1=NC=CC(CO)=C1
Density:
Catalog Number:CM178754
Molecular Weight:167.16
Boiling Point:
MDL No:MFCD09834350
Storage:Store at room temperature.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

BMF-219
Biomea Fusion’s BMF-219 demonstrates promising early signs of clinical activity, with its ability to achieve durable and sustained complete responses (CRs) and minimal residual disease negativity (MRD-neg) in patients with acute myeloid leukemia (AML). Biomea Fusion recently presents this First Complete Responder from Ongoing Phase I Study at the 2023 ASH.
BMF-219 is the first and only covalent menin inhibitor in clinical development for AML, ALL, DLBCL, MM and CLL. Additionally, BMF-219 is being explored for its potential to regenerate insulin-producing beta cells as a treatment of type 1 diabetes.